Gateway® M0032072215150Recalls & reported problems
Boston Scientific Corporation · PTA Balloon Catheter · Class f
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729791300), received between Sep 20, 2016 and Dec 27, 2021 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Material Rupture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Rupture1
Patient problems
- Hemorrhage, Subarachnoid1
- Infarction, Cerebral1
- Neurological Deficit/Dysfunction1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 27, 2021Material Rupture; Material Rupture
IT WAS REPORTED THAT THE SUBJECT BALLOON COULD NOT INFLATE DURING AN INTRACRANIAL ARTERY STENOSIS PROCEDURE. UPON REMOVAL, THE PHYSICIAN NOTED THE BALLOON (SUBJECT DEVICE) HAS RUPTURED. THE PATIENT'S ANATOMY WAS MODERATELY TORTUOUS. THE PHYSICIAN REPLACED IT WITH A NEW DEVICE AND CONTINUED THE PROCEDURE WITHOUT CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13087159 ↗InjurySep 18, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT STENT ASSISTED BALLOON(SUBJECT DEVICE) ANGIOPLASTY OF THE BASILAR TRUNK ARTERY STENOSIS WITH THE SUCCESSFUL IMPLANTATION OF THE FIRST STENT. IT WAS REPORTED THAT DURING THE PLACEMENT OF THE SECOND STENT, THE STENT FAILED TO OPEN AND HENCE IT WAS NOT IMPLANTED. THE NEXT DAY OF THE PROCEDURE, TRACE AMOUNT OF SUBARACHNOID HEMORRHAGE WITHIN INTERPEDUNCULAR AND PREPONTINE CISTERN WAS OBSERVED. THE HEMORRHAGE WAS RESOLVED WITHOUT ANY RESIDUAL EFFECTS. NO TREATMENT WAS ADMINISTERED IN THE PHYSICIAN¿S OPINION, THE CAUSE OF THE HEMORRHAGE IS RELATED TO THE PROCEDURE; HOWEVER, RELATIONSHIP TO THE STENT AND THE BALLOON IS UNKNOWN.
Patient problems: Hemorrhage, Subarachnoid
MAUDE report 6874367 ↗InjurySep 20, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT WITH A BASELINE OF A MODIFIED RANKIN SCALE (MRS) OF 3 UNDERWENT SUCCESSFUL STENT ASSISTED BALLOON ANGIOPLASTY OF THE 87 % STENOSED LEFT MIDDLE CEREBRAL ARTERY (L MCA). IT WAS REPORTED THAT POST PROCEDURE THE PATIENT EXPERIENCED A STROKE IN THE BASAL GANGLIA (TREATED AREA). THE PATIENT STROKE WAS ASSESSED AS A MRS OF 4 WITH A NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) OF 12. IT WAS REPORTED THAT MEDICAL THERAPY AND REHABILITATION HAVE BEEN PROVIDED AND IT IS STILL ONGOING. AT DISCHARGE THE PATIENT HAD RESIDUAL APHASIA AND RIGHT SIDED WEAKNESS. UPON DISCHARGE THE PATIENT WAS REPORTED TO HAVE A MRS OF 4 WITH A NIHSS OF 9. THE STUDY FACILITY INDICATED THAT THE RELATIONSHIP OF THE PROCEDURE TO THE STROKE WAS NOT RELATED; HOWEVER, TO THE DEVICE WAS UNKNOWN.
Patient problems: Infarction, Cerebral; Neurological Deficit/Dysfunction
MAUDE report 5963866 ↗
Other intracranial neurovascular stent devices
- CERENOVUS ENTERPRISE ENF402312Medos International Sàrl · intracranial neurovascular stent1 death90 reports
- PulseRider Aneurysm Neck Reconstruction Device 201-DMedos International Sàrl · Intracranial Neurovascular Stent2 deaths74 reports
- CERENOVUS ENTERPRISE ENF402300Medos International Sàrl · intracranial neurovascular stent2 deaths66 reports
- CERENOVUS ENTERPRISE ENF403012Medos International Sàrl · intracranial neurovascular stent1 death42 reports
- CERENOVUS ENTERPRISE ENF452212Medos International Sàrl · intracranial neurovascular stent41 reports
- CERENOVUS ENTERPRISE ENF401600Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF401612Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF452812Medos International Sàrl · intracranial neurovascular stent31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page